Relay Therapeutics: Trying To Find That Right Price #Relay #Therapeutics #Find #Price
Tag: Therapeutics
Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher
Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher…
Summit Therapeutics: Not Pharmacyclics, Not Yet
Summit Therapeutics: Not Pharmacyclics, Not Yet #Summit #Therapeutics #Pharmacyclics
Adar1 capital management increases stake in Keros Therapeutics with $328k purchase
Adar1 capital management increases stake in Keros Therapeutics with $328k purchase#Adar1 #capital #management #increases #stake #Keros…
Adar1 partners increases stake in Keros Therapeutics with $9.1m purchase
Adar1 partners increases stake in Keros Therapeutics with $9.1m purchase#Adar1 #partners #increases #stake #Keros #Therapeutics #9.1m…
Y-mAbs Therapeutics: A Yawn From The Market Means Opportunity
Y-mAbs Therapeutics: A Yawn From The Market Means Opportunity #YmAbs #Therapeutics #Yawn #Market #Means #Opportunity
Keros Therapeutics: A Biotech Stock on the Move Amid Strategic Review and Rights Plan
In a move that’s got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of…
Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story
Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story #Sage #Therapeutics #Speculative…
Akero Therapeutics: Cirrhosis Reversal Data Derisks The Stock (NASDAQ:AKRO)
This article was written by Follow Avisol Capital Partners is made up of a team of…
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation…
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock
OrbiMed Advisors LLC purchases $10 million in Edgewise Therapeutics stock#OrbiMed #Advisors #LLC #purchases #million #Edgewise #Therapeutics…
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292#Bicycle #therapeutics #CTO #Michael #Skynner #sells #shares #worth
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal
Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal #Sangamo #Therapeutics #Scope #Eli…
Pliant Therapeutics: An Activist On Deck
Pliant Therapeutics: An Activist On Deck #Pliant #Therapeutics #Activist #Deck
Zevra Therapeutics: Mixed Feelings On Miplyffa Approval
Zevra Therapeutics: Mixed Feelings On Miplyffa Approval #Zevra #Therapeutics #Mixed #Feelings #Miplyffa #Approval
Corcept therapeutics officer sells $20.2 million in stock
Corcept therapeutics officer sells $20.2 million in stock#Corcept #therapeutics #officer #sells #million #stock
Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company…
Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript
Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study…
Corcept Therapeutics: A Stock on the Rise, But Is It a Buy?
As an investor, it’s always exciting to see a stock surge in value. And Corcept Therapeutics…
Soleno Therapeutics: A Breakthrough in Rare Disease Treatment
The biotech world is buzzing with excitement as Soleno Therapeutics (SLNO) has just received FDA approval…